Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment
Open Access
- 1 December 2017
- journal article
- Published by Elsevier in Medical Mycology Case Reports
- Vol. 18, 15-17
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled TrialOpen Forum Infectious Diseases, 2016
- Probiotics for the prevention of antibiotic-associated diarrhoea in older patients: A systematic reviewTravel Medicine and Infectious Disease, 2015
- Saccharomyces Cerevisiae Fungemia, a Possible Consequence of the Treatment of Clostridium Difficile Colitis with a ProbioticumInternational Journal of Immunopathology and Pharmacology, 2014
- Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probioticsJournal of Medical Microbiology, 2012
- Effectiveness and safety ofSaccharomyces boulardiifor acute infectious diarrheaExpert Opinion on Biological Therapy, 2012
- Microbiota and enteral nutritionGastroentérologie Clinique Et Biologique, 2010
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)Infection Control & Hospital Epidemiology, 2010
- Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofunginCritical Care, 2008
- The Taxonomic Position of Saccharomyces boulardii as Evaluated by Sequence Analysis of the D1/D2 Domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 Region and the Mitochondrial Cytochrome-c Oxidase II GeneSystematic and Applied Microbiology, 2003
- Seven cases of fungemia with Saccharomyces boulardii in critically ill patientsIntensive Care Medicine, 2002